We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bleeding Symptoms of Carriers of Hemophilia A and B

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01029808
First Posted: December 10, 2009
Last Update Posted: October 19, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Anna Olsson, Sahlgrenska University Hospital, Sweden
  Purpose
To collect and analyze data on female carriers of severe and moderate hemophilia A and B.

Condition
Hemophilia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Bleeding Symptoms of Carriers of Hemophilia A and B

Resource links provided by NLM:


Further study details as provided by Anna Olsson, Sahlgrenska University Hospital, Sweden:

Primary Outcome Measures:
  • Bleeding tendency in carriers of severe and moderate haemophilia compared to a control group. [ Time Frame: Five years ]

Enrollment: 126
Study Start Date: December 2009
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Carriers of severe and moderate hemophilia A and B
Criteria

Inclusion Criteria:

  • Female carriers of hemophilia A and B.

Exclusion Criteria:

  • Pregnancy.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01029808


Locations
Sweden
Sahlgrenska university hospital
Göteborg, Sweden, 41345
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
Investigators
Study Chair: Fariba Baghaei, MD PhD
  More Information

Publications:
Responsible Party: Anna Olsson, MD, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier: NCT01029808     History of Changes
Other Study ID Numbers: VGAO002
First Submitted: December 9, 2009
First Posted: December 10, 2009
Last Update Posted: October 19, 2016
Last Verified: October 2016

Keywords provided by Anna Olsson, Sahlgrenska University Hospital, Sweden:
carriers of hemophilia

Additional relevant MeSH terms:
Hemophilia A
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn
Factor VIII
Coagulants